DTU
DTU

Conference abstracts (8 of 182)

Years :

Search conference abstracts :

2000

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Sulphonylurea Therapy Over Six Years Does Not Delay Progression To Diabetes
Herlihy OM, Morris RJ, Karunakaran S, Holman RR
Diabetologia 2000;43:Suppl1:A73
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Reinforced Healthy Living Advice Over Six Years Does Not Delay Progression To Diabetes
Dyson PA, Mehta Z, Hammersley M, Holman RR
Diabetologia 2000;43:Suppl1:A114
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
Cull CA, Wright AD, Holman RR
Diabetologia 2000;43:Suppl 1:A40
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Butyrylcholinesterase K variant is associated with type 2 diabetes in UK caucasians
Hashim Y, Shepherd D, Wiltshire S, Clarke A, Holman RR
Diabetologia 2000;43:Suppl 1:A51
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Possible prevention of type 2 diabetes with acarbose or metformin over three years
Citroën HA, Tunbridge FKE, Holman RR
Diabetologia 2000;43:Suppl 1:A73
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
ApoE ε2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
Horton VA, Groves CJ, Naylor M, Owen R, Wiltshire S, Stratton IM, Green F, Holman RR
Diabetologia 2000;43:Suppl 1:A86
[Abstract]

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem
Standardised HbA1c measurements are essential for the management of glycaemia as a risk factor in diabetes
Manley SE, Holman RR
Diabetologia 2000;43:Suppl 1:A232
[Abstract]

60th Scientific Sessions of the American Diabetes Association, San Antonio
Possible Prevention of Type 2 Diabetes with Acarbose or Metformin
Holman RR, North BV, Tunbridge FK
Diabetes 2000;40:(Suppl 1):A111
[Abstract]